(Q38363061)

2 September 2017

Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors (English)

1 reference

2 September 2017

0 references

Vaclav Vetvicka

1

1 reference

PubMed ID

12224027

2 September 2017

Petr Benes

series ordinal

2

1 reference

PubMed ID

12224027

2 September 2017

Martin Fusek

series ordinal

3

1 reference

2 September 2017

1 October 2002

1 reference

2 September 2017

1 reference

2 September 2017

9

1 reference

2 September 2017

10

1 reference

2 September 2017

854-863

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700508

2 September 2017

0 references

cites work

Assembly of asparagine-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Evolution in the structure and function of aspartic proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Immunoinhibition of intracellular protein digestion in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Isolation of a membrane-associated cathepsin D-like enzyme from the model antigen presenting cell, A20, and its ability to generate antigenic fragments from a protein antigen in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

The macrophage and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Immunolocalization of cathepsin D in normal and neoplastic human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D in breast cancer: a tissue marker associated with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Estrogen receptors and cathepsin D in human thyroid tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Effect of procathepsin D and its activation peptide on prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Micro-lymph node metastasis and its correlation with cathepsin D expression in early gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Effect of human procathepsin D on proliferation of human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Activation of peripheral blood neutrophils and lymphocytes by human procathepsin D and insulin-like growth factor II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Analysis of the interaction of procathepsin D activation peptide with breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Oestrogens, proteases and breast cancer. From cell lines to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Lysosomal enzymes and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Molecular recognition and targeting of lysosomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Mitogenic function of human procathepsin D: the role of the propeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Biological and clinical significance of cathepsin D in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Immunohistochemical studies concerning cathepsin D in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Human procathepsin D: three-dimensional model and isolation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Role of procathepsin D activation peptide in prostate cancer growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700508

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700508

1 reference

2 September 2017

1 reference

PubMed ID

12224027